{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T13:14:58Z","timestamp":1789737298419,"version":"4.0.1"},"reference-count":41,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2012,1,1]],"date-time":"2012-01-01T00:00:00Z","timestamp":1325376000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2012,1]]},"DOI":"10.1016\/j.ejps.2011.10.022","type":"journal-article","created":{"date-parts":[[2011,11,11]],"date-time":"2011-11-11T05:45:51Z","timestamp":1320990351000},"page":"90-100","source":"Crossref","is-referenced-by-count":39,"title":["Efficacy, nephrotoxicity and ototoxicity of aminoglycosides, mathematically modelled for modelling-supported therapeutic drug monitoring"],"prefix":"10.1016","volume":"45","author":[{"given":"Sander","family":"Croes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arjen H.","family":"Koop","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephan A.","family":"van Gils","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cees","family":"Neef","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejps.2011.10.022_b0005","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/S0002-9343(02)01476-6","article-title":"Pharmacokinetic dosing of aminoglycosides: a controlled trial","volume":"114","author":"Bartal","year":"2003","journal-title":"Am. J. Med."},{"key":"10.1016\/j.ejps.2011.10.022_b0010","series-title":"Physiology","author":"Berne","year":"2003"},{"key":"10.1016\/j.ejps.2011.10.022_b0015","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1097\/00129492-200407000-00025","article-title":"Permanent gentamicin vestibulotoxicity","volume":"25","author":"Black","year":"2004","journal-title":"Otol. Neurotol."},{"key":"10.1016\/j.ejps.2011.10.022_b0020","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/0041-008X(89)90219-6","article-title":"Isolated proximal tubular cells from rat kidney as an in vitro model for studies on nephrotoxicity. I. An improved method for preparation of proximal tubular cells and their functional characterization by alpha-methylglucose uptake","volume":"101","author":"Boogaard","year":"1989","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.ejps.2011.10.022_b0025","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1086\/595011","article-title":"Bad bugs, no drugs: no ESKAPE! An update from the Infectious Diseases Society of America","volume":"48","author":"Boucher","year":"2009","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.ejps.2011.10.022_b0030","series-title":"The Kidney","author":"Brenner","year":"2000"},{"key":"10.1016\/j.ejps.2011.10.022_b0035","unstructured":"Carri\u00e8re, E.G.J., 1980. Gehoorbeschadiging door gentamicine, een klinisch en dierexperimenteel onderzoek. Delft, The Netherlands."},{"key":"10.1016\/j.ejps.2011.10.022_b0040","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.heares.2006.05.008","article-title":"Aspirin attenuates gentamicin ototoxicity: from the laboratory to the clinic","volume":"226","author":"Chen","year":"2007","journal-title":"Hear. Res."},{"key":"10.1016\/j.ejps.2011.10.022_b0045","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1128\/AAC.42.7.1731","article-title":"Comparisons between antimicrobial pharmacodynamic indices and bacterial killing as described by using the Zhi model","volume":"42","author":"Corvaisier","year":"1998","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejps.2011.10.022_b0050","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1007\/s10928-007-9069-x","article-title":"Mechanism-based pharmacokinetic\u2013pharmacodynamic modeling of antimicrobial drug effects","volume":"34","author":"Czock","year":"2007","journal-title":"J. Pharmacokinet Pharmacodyn."},{"key":"10.1016\/j.ejps.2011.10.022_b0055","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1007\/978-1-4684-8953-8_22","article-title":"Aminoglycoside nephrotoxicity: mechanism and prevention","volume":"252","author":"De Broe","year":"1989","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.ejps.2011.10.022_b0060","first-page":"83","article-title":"Insights into the renal handling of aminoglycosides: a guideline for prevention of nephrotoxicity","volume":"1","author":"De Broe","year":"1988","journal-title":"J Drug Dev"},{"key":"10.1016\/j.ejps.2011.10.022_b0065","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/S0272-6386(86)80101-9","article-title":"The effect of dosing strategy on kidney cortical accumulation of aminoglycosides in rats","volume":"8","author":"Giuliano","year":"1986","journal-title":"Am. J. Kidney Dis."},{"key":"10.1016\/j.ejps.2011.10.022_b0070","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/S0022-3565(25)38916-0","article-title":"In vivo uptake kinetics of aminoglycosides in the kidney cortex of rats","volume":"236","author":"Giuliano","year":"1986","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejps.2011.10.022_b0075","first-page":"234","article-title":"Comparison of four methods for predicting serum gentamicin concentrations in surgical patients with perforated or gangrenous appendicitis","volume":"6","author":"Hurst","year":"1987","journal-title":"Clin. Pharm."},{"key":"10.1016\/j.ejps.2011.10.022_b0080","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1016\/S0140-6736(71)92283-5","article-title":"Estimation of creatinine clearance from changing serum\u2013creatinine levels","volume":"2","author":"Jelliffe","year":"1971","journal-title":"Lancet"},{"key":"10.1016\/j.ejps.2011.10.022_b0085","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/S1473-3099(05)70218-8","article-title":"Continuous versus intermittent intravenous administration of antibiotics: a meta-analysis of randomised controlled trials","volume":"5","author":"Kasiakou","year":"2005","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.ejps.2011.10.022_b0090","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1177\/0091270004266633","article-title":"Application of Bayes theorem to aminoglycoside-associated nephrotoxicity: comparison of extended-interval dosing, individualized pharmacokinetic monitoring, and multiple-daily dosing","volume":"44","author":"Kim","year":"2004","journal-title":"J. Clin. Pharmacol."},{"key":"10.1016\/j.ejps.2011.10.022_b0095","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1042\/cs0770105","article-title":"Circadian rhythm of glomerular filtration rate in normal individuals","volume":"77","author":"Koopman","year":"1989","journal-title":"Clin. Sci. (Lond.)"},{"key":"10.1016\/j.ejps.2011.10.022_b0100","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1681\/ASN.V4181","article-title":"Can pharmacokinetic dosing decrease nephrotoxicity associated with aminoglycoside therapy","volume":"4","author":"Leehey","year":"1993","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.ejps.2011.10.022_b0105","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/S0924-8579(02)00030-4","article-title":"Extended interval aminoglycoside dosing: from concept to clinic","volume":"19","author":"Maglio","year":"2002","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.ejps.2011.10.022_b0110","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1128\/AAC.43.5.1003","article-title":"Aminoglycosides: nephrotoxicity","volume":"43","author":"Mingeot-Leclercq","year":"1999","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejps.2011.10.022_b0115","series-title":"Mathematical Biology","author":"Murray","year":"1989"},{"key":"10.1016\/j.ejps.2011.10.022_b0120","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/S0010-4825(02)00035-5","article-title":"Analogy between temperature-dependent and concentration-dependent bacterial killing","volume":"32","author":"Neef","year":"2002","journal-title":"Comput. Biol. Med."},{"key":"10.1016\/j.ejps.2011.10.022_b0125","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1128\/AAC.39.3.650","article-title":"Experience with a once-daily aminoglycoside program administered to 2184 adult patients","volume":"39","author":"Nicolau","year":"1995","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejps.2011.10.022_b0130","unstructured":"Prins, J.M., 1995. Antimicrobial therapy of severe Gram-negative infections, dosing of aminoglycoside and studies on endotoxin release. De Meern, The Netherlands."},{"key":"10.1016\/j.ejps.2011.10.022_b0135","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/0140-6736(93)90137-6","article-title":"Once versus thrice daily gentamicin in patients with serious infections","volume":"341","author":"Prins","year":"1993","journal-title":"Lancet"},{"key":"10.1016\/j.ejps.2011.10.022_b0140","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1128\/AAC.47.3.1010-1016.2003","article-title":"Aminoglycoside nephrotoxicity: modeling, simulation, and control","volume":"47","author":"Rougier","year":"2003","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejps.2011.10.022_b0145","doi-asserted-by":"crossref","first-page":"493","DOI":"10.2165\/00003088-200342050-00007","article-title":"Aminoglycoside dosages and nephrotoxicity: quantitative relationships","volume":"42","author":"Rougier","year":"2003","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.ejps.2011.10.022_b0150","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1146\/annurev.pa.26.040186.000455","article-title":"Drug ototoxicity","volume":"26","author":"Rybak","year":"1986","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.ejps.2011.10.022_b0155","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1128\/AAC.43.7.1549","article-title":"Prospective evaluation of the effect of an aminoglycoside dosing regimen on rates of observed nephrotoxicity and ototoxicity","volume":"43","author":"Rybak","year":"1999","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejps.2011.10.022_b0160","series-title":"The Aminoglycosides, Microbiology, Clinical Use and Toxicology","first-page":"143","article-title":"Aminoglycoside pharmacokinetics as a guide to therapy and toxicology","author":"Schentag","year":"1988"},{"key":"10.1016\/j.ejps.2011.10.022_b0165","series-title":"The in vivo study of drug action","author":"Van Boxtel","year":"1992"},{"key":"10.1016\/j.ejps.2011.10.022_b0170","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/S0272-6386(86)80102-0","article-title":"Renal cortical uptake kinetics of gentamicin in rats with impaired renal function","volume":"8","author":"Verpooten","year":"1986","journal-title":"Am. J. Kidney Dis."},{"key":"10.1016\/j.ejps.2011.10.022_b0175","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/S0924-8579(02)00023-7","article-title":"The application of population pharmacokinetic modeling to individualized antibiotic therapy","volume":"19","author":"Vinks","year":"2002","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.ejps.2011.10.022_b0180","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1093\/jac\/40.1.125","article-title":"Continuous infusion of ceftazidime in cystic fibrosis patients during home treatment: clinical outcome, microbiology and pharmacokinetics","volume":"40","author":"Vinks","year":"1997","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.ejps.2011.10.022_b0185","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1007\/s10928-007-9071-3","article-title":"Physiologically based pharmacokinetic modelling: a sub-compartmentalized model of tissue distribution","volume":"34","author":"von Kleist","year":"2007","journal-title":"J. Pharmacokinet Pharmacodyn."},{"key":"10.1016\/j.ejps.2011.10.022_b0190","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.jconrel.2003.12.005","article-title":"Targeted prevention of renal accumulation and toxicity of gentamicin by aminoglycoside binding receptor antagonists","volume":"95","author":"Watanabe","year":"2004","journal-title":"J. Control Release"},{"key":"10.1016\/j.ejps.2011.10.022_b0195","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S0002-9343(03)00012-3","article-title":"Once-daily dosing of aminoglycosides: how much monitoring is truly required?","volume":"114","author":"Winston","year":"2003","journal-title":"Am. J. Med."},{"key":"10.1016\/j.ejps.2011.10.022_b0200","doi-asserted-by":"crossref","unstructured":"Zavascki, A.P., 2006. Continuous intravenous administration of antibiotics. Lancet Infect. Dis. 6, 259 [author reply 259\u2013260].","DOI":"10.1016\/S1473-3099(06)70446-7"},{"key":"10.1016\/j.ejps.2011.10.022_b0205","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1002\/jps.2600751108","article-title":"A pharmacodynamic model for the activity of antibiotics against microorganisms under nonsaturable conditions","volume":"75","author":"Zhi","year":"1986","journal-title":"J. Pharm. Sci."}],"container-title":["European Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098711003824?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098711003824?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,14]],"date-time":"2025-03-14T00:06:32Z","timestamp":1741910792000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0928098711003824"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,1]]},"references-count":41,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2012,1]]}},"alternative-id":["S0928098711003824"],"URL":"https:\/\/doi.org\/10.1016\/j.ejps.2011.10.022","relation":{},"ISSN":["0928-0987"],"issn-type":[{"value":"0928-0987","type":"print"}],"subject":[],"published":{"date-parts":[[2012,1]]}}}